RPG Life Sciences Limited
NSE: RPGLIFE BSE: RPGLIFE
NSE
2,390.00
9.70 (0.41%)
Prev Close
2380.3
Open Price
2380.3
Volume
8,166
Today Low / High
2350 / 2415
52 WK Low / High
1835 / 2974.95
Range
2,271 - 2,510
BSE
2,384.00
5.55 (0.23%)
Prev Close
2378.45
Open Price
2380
Volume
311
Today Low / High
2351.75 / 2416.6
52 WK Low / High
1772.05 / 2976.7
Range
2,265 - 2,503
The stock is currently trading on both the National Stock Exchange (NSE) and Bombay Stock Exchange (BSE). On the NSE, the stock is priced at 2390 (target range: 2,271 - 2,510), reflecting a change of 9.7 (0.40751%). On the BSE, it is listed at 2384 (target range: 2,265 - 2,503), showing a change of 5.55 (0.23335%). Both the NSE and BSE data indicate positive movement, suggesting the stock is on an upward trend. This could be an attractive opportunity for investors looking for growth.
15 Sep
2,380.30
0.21%
12 Sep
2,383.00
-0.11%
11 Sep
2,401.60
-0.52%
10 Sep
2,396.00
0.23%
09 Sep
2,387.00
0.38%
08 Sep
2,398.00
-1.04%
05 Sep
2,372.90
0.21%
04 Sep
2,385.50
-0.49%
03 Sep
2,326.10
1.85%
02 Sep
2,338.60
-0.11%
01 Sep
2,302.10
1.64%
29 Aug
2,310.40
0.44%
28 Aug
2,301.50
1.06%
26 Aug
2,361.00
-2.52%
25 Aug
2,368.00
-0.88%
22 Aug
2,340.80
0.74%
21 Aug
2,359.00
-0.77%
20 Aug
2,291.00
2.30%
19 Aug
2,289.90
0.05%
18 Aug
2,278.50
0.22%
RPG Life Sciences Limited Graph
RPG Life Sciences Limited Price Target Predictions: Bullish vs. Bearish Scenarios with Ranges
If you are looking for the target price for RPG Life Sciences Limited T1, T2, T3 for both Bullish and Bearish scenarios, here it is. For Bullish: T1, T2, T3. For Bearish: T1, T2, T3. The stock current price is 2,390.00, with potential price targets ranging from T1, T2, and T3 in both directions based on market conditions.
| Scenario | Price | Target | Range |
|---|---|---|---|
| Bullish Scenario | 2,384.00 | 2,407.84 | 2,167.06 - 2,648.62 |
| 2,431.68 | 1,945.34 - 2,918.02 | ||
| 2,455.52 | 1,718.86 - 3,192.18 | ||
| Bearish Scenario | 2,384.00 | 2,360.16 | 2,124.14 - 2,596.18 |
| 2,336.32 | 1,869.06 - 2,803.58 | ||
| 2,312.48 | 1,618.74 - 3,006.22 |
Overview of RPG Life Sciences Limited
ISIN
INE105J01010
Industry
Drug Manufacturers - Specialty & Generic
Vol.Avg
24,115
Market Cap
39,448,822,800
Last Dividend
20
Official Website
IPO Date
2002-08-12
DCF Diff
-4,161.83
DCF
6,513
Financial Ratios Every Investor Needs
Stock Dividend of RPGLIFE
| Date | Label | Adj Dividend | Dividend | Record Date | Payment Date | Declaration Date |
|---|---|---|---|---|---|---|
| 2025-06-27 | June 27, 25 | 20 | 20 | 2025-06-27 | 2025-08-15 | |
| 2024-06-28 | June 28, 24 | 16 | 16 | 2024-06-28 | 2024-08-15 | |
| 2023-07-21 | July 21, 23 | 12 | 12 | 2023-07-21 | 2023-09-03 | |
| 2022-07-14 | July 14, 22 | 9.6 | 9.6 | 2022-07-15 | 2022-08-28 | |
| 2021-08-13 | August 13, 21 | 7.2 | 7.2 | 2021-08-17 | 2021-09-30 |
Annual Financial Income Report
| Date | Revenue | Co.Rev | GP | GPR | R&D Expenses | G&A Expenses | Operating Income | Net Income | EPS | EBITDA | NIR |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 653.43 Cr | 214.01 Cr | 439.42 Cr | 0.6725 | 0.00 Cr | 26.71 Cr | 313.28 Cr | 183.24 Cr | 110.80 | 159.65 Cr | 0.2804 |
| 2024-03-31 | 577.48 Cr | 194.20 Cr | 383.28 Cr | 0.6637 | 9.36 Cr | 132.89 Cr | 109.99 Cr | 87.66 Cr | 53.00 | 136.35 Cr | 0.1518 |
| 2023-03-31 | 509.08 Cr | 170.87 Cr | 341.94 Cr | 0.6717 | 8.93 Cr | 18.17 Cr | 87.47 Cr | 67.64 Cr | 40.90 | 108.33 Cr | 0.1329 |
| 2022-03-31 | 437.16 Cr | 150.21 Cr | 286.95 Cr | 0.6564 | 8.97 Cr | 19.66 Cr | 70.74 Cr | 51.48 Cr | 31.13 | 90.24 Cr | 0.1178 |
| 2021-03-31 | 383.40 Cr | 137.64 Cr | 245.76 Cr | 0.6410 | 8.88 Cr | 15.17 Cr | 54.72 Cr | 40.00 Cr | 24.19 | 71.84 Cr | 0.1043 |
Annual Financials Balance Sheet
| Date | C&C Equ. | Tot. Assets | Tot. Liab. | Stock. Equity | Tot. Debt | Net Debt | Inv. | PP&E (Net) | Curr. Def. Rev. | Non-Curr. Def. Rev. | LT Invest. | Curr. Liab. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 139.61 Cr | 657.81 Cr | 127.28 Cr | 530.5300 Cr | 0.00 Cr | -139.61 Cr | 92.98 Cr | 165.13 Cr | 0.00 Cr | 0.00 Cr | 1.01 Cr | 119.8300 Cr |
| 2024-03-31 | 19.72 Cr | 512.87 Cr | 138.02 Cr | 374.8500 Cr | 0.00 Cr | -19.72 Cr | 101.00 Cr | 181.81 Cr | 1.84 Cr | 3.03 Cr | 1.20 Cr | 130.9600 Cr |
| 2023-03-31 | 24.82 Cr | 419.35 Cr | 111.75 Cr | 307.6000 Cr | 0.01 Cr | -24.81 Cr | 95.05 Cr | 116.30 Cr | 31.88 Cr | 3.02 Cr | -91.56 Cr | 102.7800 Cr |
| 2022-03-31 | 56.94 Cr | 344.61 Cr | 88.84 Cr | 255.7700 Cr | 0.94 Cr | -56.00 Cr | 82.99 Cr | 100.09 Cr | 2.46 Cr | 3.13 Cr | -12.48 Cr | 80.1100 Cr |
| 2021-03-31 | 40.36 Cr | 303.39 Cr | 86.94 Cr | 216.4500 Cr | 2.02 Cr | -38.34 Cr | 58.33 Cr | 87.94 Cr | 24.53 Cr | 0.00 Cr | -1.25 Cr | 79.6900 Cr |
Annual Financials Cash Flow Statement
| Date | Operating Cash | Investing Cash | Financing Cash | Free Cash | Cash Change | Cash at End | CapEx | Income | Debt Repay | Dividends | Inventory |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 77.8600 Cr | -41.8000 Cr | -27.0800 Cr | 41.8300 Cr | 8.9800 Cr | 28.7000 Cr | -36.0300 Cr | 183.2400 Cr | 0.0000 Cr | -26.4600 Cr | 6.1900 Cr |
| 2024-03-31 | 94.3600 Cr | -79.1500 Cr | -20.3100 Cr | 25.1300 Cr | -5.1000 Cr | 19.7200 Cr | -69.2300 Cr | 87.6600 Cr | -0.0100 Cr | -19.8500 Cr | -5.9500 Cr |
| 2023-03-31 | 90.8200 Cr | -105.8100 Cr | -17.1200 Cr | 58.0900 Cr | -32.1200 Cr | 24.8200 Cr | -32.7300 Cr | 91.6800 Cr | -0.2800 Cr | -15.8800 Cr | -12.0600 Cr |
| 2022-03-31 | 64.7500 Cr | -34.6600 Cr | -13.5100 Cr | 40.8000 Cr | 16.5800 Cr | 56.9400 Cr | -23.9500 Cr | 73.1700 Cr | -0.4200 Cr | -11.9100 Cr | -24.6600 Cr |
| 2021-03-31 | 58.2700 Cr | -7.9600 Cr | -10.4900 Cr | 49.7600 Cr | 39.8200 Cr | 40.3600 Cr | -8.5100 Cr | 53.5800 Cr | -9.0700 Cr | 0.0000 Cr | -11.7200 Cr |
Quarterly Financial Income Report
| Date | Revenue | Co.Rev | GP | GPR | Operating Income | Net Income | EPS | EBITDA | NIR |
|---|---|---|---|---|---|---|---|---|---|
| 2025-06-30 | 168.92 Cr | 60.02 Cr | 108.90 Cr | 0.6447 | 30.33 Cr | 26.29 Cr | 15.90 | 40.70 Cr | 0.1556 |
| 2025-03-31 | 143.09 Cr | 48.72 Cr | 94.37 Cr | 0.6595 | 62.77 Cr | 117.35 Cr | 70.96 | 25.48 Cr | 0.8201 |
| 2024-12-31 | 172.71 Cr | 56.11 Cr | 116.60 Cr | 0.6751 | 43.70 Cr | 34.93 Cr | 21.12 | 52.47 Cr | 0.2022 |
| 2024-09-30 | 172.21 Cr | 54.17 Cr | 118.04 Cr | 0.6854 | 40.62 Cr | 4.20 Cr | 2.54 | 20.57 Cr | 0.0244 |
| 2024-06-30 | 165.42 Cr | 93.04 Cr | 72.38 Cr | 0.4376 | 33.78 Cr | 26.76 Cr | 16.18 | 41.44 Cr | 0.1618 |
Quarterly Financials Balance Sheet
| Date | Cash & Equiv. | Short-Term Inv. | Cash & Short-Term | Net Receivables | Inventory | Total Curr. Assets | PP&E (Net) | Total Assets | Total Liabilities |
|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 139.61 Cr | 235.90 Cr | 265.51 Cr | 86.76 Cr | 92.98 Cr | 465.25 Cr | 165.13 Cr | 657.81 Cr | 127.28 Cr |
| 2024-12-31 | 0.00 Cr | 0.00 Cr | 125.94 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | -379.38 Cr |
| 2024-09-30 | 17.28 Cr | 91.91 Cr | 127.73 Cr | 86.41 Cr | 99.16 Cr | 330.17 Cr | 181.79 Cr | 554.37 Cr | 174.99 Cr |
| 2024-06-30 | -125.87 Cr | 251.74 Cr | 125.87 Cr | 0.00 Cr | 0.00 Cr | 125.87 Cr | 0.00 Cr | 0.00 Cr | -374.85 Cr |
| 2024-03-31 | 36.47 Cr | 106.15 Cr | 125.87 Cr | 49.13 Cr | 101.00 Cr | 298.09 Cr | 181.81 Cr | 512.87 Cr | 138.02 Cr |
Quarterly Financials Cash Flow Statement
| Date | Net Income | Operating Cash Flow | Investing Cash Flow | Financing Cash Flow | Net Cash Change | Cash at End | Cash at Beginning | CapEx | Free Cash Flow |
|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 117.35 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-12-31 | 34.93 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-09-30 | 4.20 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-06-30 | 26.76 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-03-31 | 13.24 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 19.72 Cr | 31.29 Cr | 0.00 Cr | 0.00 Cr |
Splits History
| Date | Label | Split Ratio |
|---|---|---|
| No split history data available. | ||
Similar Stocks: Drug Manufacturers - Specialty & Generic
| Company Name | Symbol | Price | Market Cap | Volume |
|---|---|---|---|---|
| Sun Pharmaceutical Industries Limited | SUNPHARMA | ₹1,609.00 | ₹3,860,441,520,000.00 | ₹1,626,288.00 |
| Divi's Laboratories Limited | DIVISLAB | ₹6,050.50 | ₹1,606,220,184,500.00 | ₹63,569.00 |
| Torrent Pharmaceuticals Limited | TORNTPHARM | ₹3,530.90 | ₹1,195,015,450,500.00 | ₹135,292.00 |
| Dr. Reddy's Laboratories Limited | DRREDDY | ₹1,300.70 | ₹1,082,646,847,453.00 | ₹954,623.00 |
| Mankind Pharma Limited | MANKIND | ₹2,588.90 | ₹1,068,589,227,622.00 | ₹92,714.00 |
| Zydus Lifesciences Limited | ZYDUSLIFE | ₹1,036.15 | ₹1,042,605,214,500.00 | ₹296,469.00 |
| Lupin Limited | LUPIN | ₹2,040.60 | ₹932,054,253,000.00 | ₹325,910.00 |
| Alkem Laboratories Limited | ALKEM | ₹5,506.50 | ₹658,384,672,500.00 | ₹126,076.00 |
| Aurobindo Pharma Limited | AUROPHARMA | ₹1,100.80 | ₹639,346,841,600.00 | ₹870,057.00 |
| Glenmark Pharmaceuticals Limited | GLENMARK | ₹2,100.20 | ₹592,678,540,200.00 | ₹402,431.00 |
| Laurus Labs Limited | LAURUSLABS | ₹893.00 | ₹482,063,725,000.00 | ₹396,445.00 |
| Suven Pharmaceuticals Limited | SUVENPHAR | ₹1,078.00 | ₹412,407,234,624.00 | ₹1,177,218.00 |
| Cohance Lifesciences Limited | COHANCE | ₹982.00 | ₹375,680,801,856.00 | ₹57,880.00 |
| Ipca Laboratories Limited | IPCALAB | ₹1,309.10 | ₹332,123,906,400.00 | ₹70,482.00 |
| Ajanta Pharma Limited | AJANTPHARM | ₹2,555.50 | ₹319,273,948,000.00 | ₹14,183.00 |
| J. B. Chemicals & Pharmaceuticals Limited | JBCHEPHARM | ₹1,681.60 | ₹263,331,833,600.00 | ₹78,315.00 |
| Piramal Enterprises Limited | PEL | ₹1,132.00 | ₹256,599,496,000.00 | ₹946,023.00 |
| Wockhardt Limited | WOCKPHARMA | ₹1,511.10 | ₹245,530,782,791.00 | ₹113,354.00 |
| Eris Lifesciences Limited | ERIS | ₹1,664.90 | ₹226,771,034,300.00 | ₹30,477.00 |
| AstraZeneca Pharma India Limited | ASTRAZEN | ₹9,024.50 | ₹225,612,500,000.00 | ₹7,781.00 |
| Neuland Laboratories Limited | NEULANDLAB | ₹15,790.00 | ₹202,584,121,000.00 | ₹31,902.00 |
| Alembic Pharmaceuticals Limited | APLLTD | ₹960.00 | ₹188,700,480,000.00 | ₹226,418.00 |
| Jubilant Pharmova Limited | JUBLPHARMA | ₹1,124.40 | ₹179,095,556,400.00 | ₹61,537.00 |
| Caplin Point Laboratories Limited | CAPLIPOINT | ₹2,266.90 | ₹172,310,922,730.00 | ₹101,864.00 |
| NATCO Pharma Limited | NATCOPHARM | ₹853.50 | ₹152,870,385,000.00 | ₹325,818.00 |
| Glenmark Life Sciences Limited | GLS | ₹1,086.00 | ₹133,070,838,000.00 | ₹130,938.00 |
| Granules India Limited | GRANULES | ₹531.25 | ₹128,904,625,000.00 | ₹689,565.00 |
| Procter & Gamble Health Limited | PGHL | ₹6,267.00 | ₹104,028,439,800.00 | ₹5,131.00 |
| Aarti Pharmalabs Limited | AARTIPHARM | ₹936.70 | ₹84,895,902,062.00 | ₹207,949.00 |
| Strides Pharma Science Limited | STAR | ₹887.40 | ₹81,794,053,980.00 | ₹143,336.00 |
| Shilpa Medicare Limited | SHILPAMED | ₹828.90 | ₹81,058,877,010.00 | ₹111,223.00 |
| FDC Limited | FDC | ₹465.80 | ₹75,836,898,000.00 | ₹37,634.00 |
| Suven Life Sciences Limited | SUVEN | ₹226.01 | ₹49,279,377,929.00 | ₹85,787.00 |
| Innova Captab Limited | INNOVACAP | ₹856.60 | ₹49,018,875,038.00 | ₹10,615.00 |
| Aarti Drugs Limited | AARTIDRUGS | ₹513.40 | ₹46,858,018,000.00 | ₹133,136.00 |
| Sun Pharma Advanced Research Company Limited | SPARC | ₹143.75 | ₹46,650,037,500.00 | ₹131,516.00 |
| Sequent Scientific Limited | SEQUENT | ₹183.98 | ₹46,056,633,300.00 | ₹295,810.00 |
| RPG Life Sciences Limited | RPGLIFE | ₹2,385.30 | ₹39,450,476,700.00 | ₹8,145.00 |
| Gufic Biosciences Limited | GUFICBIO | ₹365.95 | ₹36,696,734,100.00 | ₹21,786.00 |
| Orchid Pharma Limited | ORCHPHARMA | ₹707.00 | ₹35,858,403,700.00 | ₹36,027.00 |
| Unichem Laboratories Limited | UNICHEMLAB | ₹504.15 | ₹35,495,084,070.00 | ₹8,735.00 |
| IOL Chemicals and Pharmaceuticals Limited | IOLCP | ₹118.86 | ₹34,888,619,220.00 | ₹11,214,307.00 |
| Solara Active Pharma Sciences Limited | SOLARA | ₹676.15 | ₹32,558,650,950.00 | ₹52,292.00 |
| Hikal Limited | HIKAL | ₹260.75 | ₹32,150,735,750.00 | ₹115,051.00 |
| Morepen Laboratories Limited | MOREPENLAB | ₹53.52 | ₹29,326,498,080.00 | ₹1,745,659.00 |
| Indoco Remedies Limited | INDOCO | ₹294.30 | ₹27,148,556,970.00 | ₹140,867.00 |
| Alembic Limited | ALEMBICLTD | ₹104.84 | ₹26,921,024,775.00 | ₹231,892.00 |
Key Executives
Vice President of Sales & Marketing (Main Division)
Mr. Samir Rane
Gender: male
Year Born:
Head of API Operations & Procurement
Mr. Kartick C. Patra
Gender: male
Year Born:
Chief Quality Officer
Mr. Milind Gujar
Gender: male
Year Born:
MD & Additional Director
Mr. Ashok Nair
Gender: male
Year Born:
Head of Legal, Compliance Officer & Company Secretary
Mr. Rajesh Shirambekar
Gender: male
Year Born:
Chief Human Resources Officer
Ms. Sheetal Gaba
Gender: female
Year Born:
Site Head of International Formulation
Mr. Rajesh Chopra
Gender: male
Year Born:
Chief Financial Officer
Mr. Vishal Shah
Gender: male
Year Born:
FAQs about RPG Life Sciences Limited
Who is the CEO of the company?
The CEO is Ashok Nair.
What is the current market price of the stock?
The current price is ₹2,385.20.
What is the 52-week price range?
The range is ₹1835-2974.95.
What is the market capitalization of the company?
The market capitalization is ₹3,944.88 crores.
What is the dividend yield?
The dividend yield is 0.84%.
What is the Price-to-Earnings (P/E) ratio?
The P/E ratio is 21.58.
Which sector does the company belong to?
The company operates in the Healthcare sector.
What does the company do?
Overview of RPG Life Sciences Limited (ISIN: INE105J01010) is a leading Drug Manufacturers - Specialty & Generic in India. With a market capitalization of ₹3,944.88 crores and an average daily volume of 24,115 shares, it operates in the Drug Manufacturers - Specialty & Generic. The company last declared a dividend of ₹20.